Phase III Cat-PAD Follow-on Study

NCT02040844 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

430

Enrollment

INDUSTRY

Sponsor class

Conditions

Cat Allergy

Interventions

DRUG: Received Cat-PAD Treatment 1 in Study CP007 [NCT01620762]
DRUG: Received Cat-PAD Treatment 2 in Study CP007 [NCT01620762]
DRUG: Received Cat-PAD Treatment 3 in Study CP007 [NCT01620762]

Sponsor

Circassia Limited